Soru

Zorluk: OrtaEndocrinology and Metabolism

Match each patient's clinical presentation and hypothalamic-pituitary-adrenal (HPA) axis laboratory profile to the most likely underlying pathophysiologic mechanism.

  • A 45-year-old with central obesity. Labs show high 24-hour urine free cortisol, undetectable plasma ACTH, and no cortisol suppression after high-dose dexamethasone administration.Autonomous adrenocortical hypersecretion (e.g., adrenal adenoma)
  • A 35-year-old with facial plethora and striae. Labs show high 24-hour urine free cortisol, elevated plasma ACTH, and >50% cortisol suppression after high-dose dexamethasone administration.Pituitary corticotroph adenoma (Cushing disease)
  • A 65-year-old with a history of smoking and severe hypokalemia. Labs show very high 24-hour urine free cortisol, markedly elevated plasma ACTH, and no cortisol suppression after high-dose dexamethasone administration.Ectopic adrenocorticotropic hormone (ACTH) production (e.g., paraneoplastic syndrome)
  • A 30-year-old with fatigue, weight loss, and mucosal hyperpigmentation. Labs show low 8 AM serum cortisol, markedly elevated plasma ACTH, and minimal cortisol response to standard cosyntropin stimulation.Primary adrenocortical destruction (e.g., autoimmune adrenalitis)
  • A 55-year-old who abruptly stopped taking a long-term medication for rheumatoid arthritis. Labs show low 8 AM serum cortisol, low plasma ACTH, and minimal cortisol response to standard cosyntropin stimulation.Suppression of the hypothalamic-pituitary-adrenal axis by exogenous glucocorticoids

Cevap

Proper diagnosis of HPA axis disorders relies on differentiating primary adrenal pathology from central (pituitary/hypothalamic) or ectopic sources using basal ACTH levels and dynamic testing (dexamethasone suppression and cosyntropin stimulation).
Evaluating HPA axis disorders requires understanding the negative feedback loop. Cortisol excess (Cushing syndrome) is first divided into ACTH-dependent and ACTH-independent causes based on basal ACTH levels. High-dose dexamethasone suppression further differentiates ACTH-dependent causes (pituitary vs. ectopic). Cortisol deficiency (adrenal insufficiency) is divided into primary and secondary causes based on ACTH levels and the response to cosyntropin.

Adım Adım Çözüm

1
Identify the primary abnormality as either hypercortisolism (Cushing syndrome) or hypocortisolism (adrenal insufficiency) based on basal cortisol levels and clinical signs.
Patients 1, 2, and 3 have hypercortisolism; Patients 4 and 5 have hypocortisolism.
This determines the main diagnostic pathway and which dynamic tests are appropriate.
2
For hypercortisolism, evaluate the plasma ACTH level to determine ACTH dependence.
Undetectable ACTH (Patient 1) indicates an adrenal source. Elevated ACTH (Patients 2 and 3) indicates an ACTH-dependent source.
High cortisol should normally suppress ACTH. Normal or high ACTH in the setting of high cortisol is inappropriate and indicates the source of the excess is ACTH-driven.
3
For ACTH-dependent hypercortisolism, interpret the high-dose dexamethasone suppression test.
Suppression (Patient 2) indicates a pituitary adenoma. Lack of suppression (Patient 3) indicates an ectopic source.
Pituitary adenomas are partially resistant to negative feedback but will suppress with high doses of glucocorticoids, whereas ectopic tumors typically lack glucocorticoid receptors entirely.
4
For hypocortisolism, evaluate the basal ACTH level and the cortisol response to cosyntropin.
Elevated ACTH with no cosyntropin response (Patient 4) indicates primary adrenal failure. Low ACTH with a blunted cosyntropin response after abrupt medication cessation (Patient 5) indicates secondary adrenal insufficiency from prolonged HPA axis suppression.
In primary adrenal destruction, the pituitary secretes high ACTH but the adrenal gland cannot respond. In secondary suppression (e.g., from exogenous steroids), the pituitary stops secreting ACTH, leading to adrenal atrophy and a temporarily blunted response to exogenous ACTH.

Anahtar Kavram

Diagnosis of HPA axis disorders using basal ACTH levels and dynamic endocrine testing
Bu soruyu puanla